Sungjune Kim, Ph.D.
Affiliations: | 2008 | Vanderbilt University, Nashville, TN |
Area:
ImmunologyGoogle:
"Sungjune Kim"Parents
Sign in to add mentor| Luc V. Kaer | grad student | 2008 | Vanderbilt | |
| (Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim S, Wuthrick E, Blakaj D, et al. (2022) Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet (London, England) |
| Creelan BC, Wang C, Teer JK, et al. (2021) Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nature Medicine |
| Hamaidi I, Zhang L, Kim N, et al. (2020) Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells. Cell Metabolism |
| Yuan Z, Fernandez D, Dhillon J, et al. (2020) Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis. Prostate Cancer and Prostatic Diseases |
| Ahmed KA, Kim Y, Armaghani AJ, et al. (2020) Abstract OT3-10-01: Phase Ib study of stereotactic radiation and nivolumab in the management of metastatic breast cancer with brain metastases Cancer Research. 80 |
| Creelan B, Wang C, Teer J, et al. (2020) Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial Cancer Research. 80 |
| Figura N, Jain M, Sim A, et al. (2020) Predictors of Failures following Chimeric Antigen Receptor T-cell (CAR T) Therapy International Journal of Radiation Oncology Biology Physics. 108 |
| Sim AJ, Jain MD, Figura N, et al. (2019) Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma. International Journal of Radiation Oncology, Biology, Physics |
| Ahmed KA, Kim Y, Apte SM, et al. (2019) Trial in progress: Phase II study of stereotactic body radiation therapy and atezolizumab in the management of recurrent, persistent, or metastatic cervical cancer. Journal of Clinical Oncology. 37 |
| Figura N, Jain M, Sim A, et al. (2019) Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy International Journal of Radiation Oncology*Biology*Physics. 105: S66-S67 |